Keyphrases
Clinical Significance
100%
Wnt Signaling Pathway
100%
Endometrioid Endometrial Carcinoma
100%
Pathway Activation
100%
CTNNB1 mutation
100%
CTNNB1
37%
Cancer Genome Atlas
25%
Exon 3
25%
RNA Sequencing (RNA-seq)
12%
Tumor
12%
Catenin
12%
Whole Exome Sequencing
12%
Signaling Activation
12%
Young Women
12%
Overall Survival
12%
Clinical Features
12%
Path Analysis
12%
Clinical Data
12%
Profile Data
12%
Survival Analysis
12%
Clinical Heterogeneity
12%
Statistical Test
12%
Obese Patients
12%
Clinical Course
12%
High-level Expression
12%
Expression Level
12%
Chi-square
12%
Kruskal-Wallis Test
12%
Molecular Fingerprints
12%
Endometrial Carcinoma
12%
Cyclin D1 (CCND1)
12%
Log-rank Test
12%
Mutation Rate
12%
Personalized Care
12%
Marker Genes
12%
Most Common Form
12%
Fisher
12%
Molecular Subtypes
12%
Mutation Data
12%
Mutation Spectrum
12%
Characteristic Spectrum
12%
Mann-Whitney
12%
Low Stage
12%
Significance Analysis of Microarrays
12%
Feature Data
12%
Transcriptome Subtypes
12%
Biochemistry, Genetics and Molecular Biology
Wnt Signaling Pathway
100%
Exon
100%
RNA Sequence
50%
Catenin
50%
Exome Sequencing
50%
Overall Survival
50%
Statistical Test
50%
Mutation Rate
50%
Marker Gene
50%
Significance Analysis of Microarrays
50%
Transcriptome
50%
Medicine and Dentistry
Endometrium Carcinoma
100%
Clinical Significance
100%
Wnt Signaling
100%
Exon
22%
The Cancer Genome Atlas
22%
RNA Sequence
11%
Clinical Feature
11%
Overall Survival
11%
Patient Care
11%
Tumor
11%
Disease Course
11%
Kruskal Wallis Test
11%
Finger Dermatoglyphics
11%
Survival Analysis
11%
Exome Sequencing
11%
Catenin
11%
Log Rank Test
11%
Transcriptome
11%
Mutation Rate
11%
Marker Gene
11%
Significance Analysis of Microarrays
11%